Browsing Tag
BSE
144 posts
LTTS to divest SWC business to AMI Paradigm in Rs 452cr slump sale
LTTS to sell its Smart World and Communication unit for Rs 452 crore to refocus on Engineering Intelligence. Read the full strategic analysis here.
Thomas Cook India demerges resorts arm into Sterling Holiday Resorts, paving way for separate BSE and NSE listing
Thomas Cook India demerges Sterling Holiday Resorts in a multi-step capital overhaul. Read the full analysis of what this means for THOMASCOOK shareholders.
Alkem Laboratories (NSE: ALKEM) expands EU GMP-certified manufacturing network and commits Rs 533cr to Ujjain greenfield plant
Alkem Laboratories secures EU GMP approval for Daman plant and commits INR 533 crore to a greenfield facility in Ujjain's DMIC corridor. Read the full strategic analysis.
HDFCBANK hits 52-week low after chairman cites ethics in shock resignation; Keki Mistry named interim chair
HDFC Bank chairman resigns citing ethics concerns as HDFCBANK falls 5%. Read what Keki Mistry told investors and what it means for the bank's future.
VA Tech Wabag (NSE: WABAG) bags Georgia wastewater contract, marking CIS region debut
VA Tech Wabag wins EIB-funded USD 30-75M Georgia WWTP contract, entering the CIS region. Read what the Kutaisi order means for WABAG's order book and strategy.
Awfis Space Solutions (NSE: AWFIS) crosses 100 South India centres as GCC demand reshapes the flexible workspace market
Awfis Space Solutions crosses 100 South India centres with 70,000 seats and 21% GCC revenue. Read what this means for AWFIS investors and the flex workspace sector.
Tata Motors (NSE: TMCV) secures pan-India orders for over 5,000 buses from nine STUs in fleet renewal sweep
Tata Motors (TMCV) wins 5,000+ bus orders from nine STUs across India. See what it means for the stock, Ashok Leyland competition, and India's mass transit future. Read more.
Zydus (NSE: ZYDUSLIFE) unit Sentynl adds Korean progeria drug Progerinin to rare disease portfolio as Phase 2A data loom
Sentynl, Zydus Lifesciences' US subsidiary, licenses Progerinin from Korea's PRG S&T for progeria. Phase 2A data due H1 2026. Read the full analysis.
Kalpataru Projects (NSE: KPIL) FY26 order book races past Rs 22,000cr with fresh Rs 2,471cr wins
KPIL wins Rs 2,471 crore in orders covering underground metro rail, T&D, and B&F, lifting FY26 intake to Rs 22,000 crore. Read the full analyst briefing.
Heritage Foods opens Shamirpet ice cream plant as HERITGFOOD seeks fivefold revenue jump
Heritage Foods opens its Shamirpet ice cream plant targeting fivefold revenue growth. What this means for HERITGFOOD investors and Indian dairy rivals. Read more.